Skip to main content
Top
Published in: Annals of Surgical Oncology 1/2007

01-01-2007

Clinicopathologic Prognostic Factors in Myxoid Liposarcoma: A Retrospective Study of 49 Patients With Long-Term Follow-Up

Authors: Suzan E. ten Heuvel, MD, Harald J. Hoekstra, MD, PhD, Robert J. van Ginkel, MD, PhD, Esther Bastiaannet, MSc, Albert J. H. Suurmeijer, MD, PhD

Published in: Annals of Surgical Oncology | Issue 1/2007

Login to get access

Abstract

Background

The main goal of this retrospective study was to investigate prognostic factors influencing the survival of myxoid liposarcoma (MLS) with emphasis on the role of transitional areas (TLS) and round cell morphology (RCLS).

Methods

From 1977 to 2004, 49 patients—28 men (57%) and 21 women (43%) with a median age of 44 years (range, 7–83 years)—were diagnosed with an MLS. In 42 patients, the histology could be reviewed, and tumors were classified as MLS, TLS, or RCLS. Clinicopathologic factors were analyzed for influence on survival by univariate and multivariate methods.

Results

The median follow-up of 49 patients was 101 months (range, 4–550 months). Of the 42 patients for whom histology was reviewed, 16 tumors were classified as MLS (38%), 19 as TLS (45%), and 7 as RCLS (17%). Sixteen patients (33%) developed a local recurrence after a median follow-up of 21 months (range, 2–108 months). Thirteen patients (27%) developed metastases. The median interval between diagnosis and metastasis was 41 months (range, 0–222 months). Median survival after metastasis was 18 months (range, 1–179 months). The 5- and 10-year disease-specific survival rates were 85% and 72%, whereas the 5- and 10-year overall survival rates were 83% and 68%, respectively. Age at presentation (P = .02), tumor grade (P = .01), and tumor size (P = .005) were significant prognostic factors associated with survival. Tumor grade was the only independent prognostic variable that remained significant with multivariate analysis. A TLS presentation had no negative influence on patient survival.

Conclusions

Age at presentation, tumor grade, and tumor size had a negative influence on survival by univariate analysis, whereas tumor grade was the only independent prognostic factor by multivariate analysis. TLS was not associated with poor outcome.
Literature
1.
go back to reference Antonescu CR, Ladanyi M. Myxoid liposarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002:40–3 Antonescu CR, Ladanyi M. Myxoid liposarcoma. In: Fletcher CDM, Unni KK, Mertens F, eds. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press, 2002:40–3
2.
go back to reference Enzinger FM, Weiss SM. Liposarcoma. In: Enzinger FM, Weiss SM, eds. Soft Tissue Tumors. St. Louis: Mosby, 2001:641–93 Enzinger FM, Weiss SM. Liposarcoma. In: Enzinger FM, Weiss SM, eds. Soft Tissue Tumors. St. Louis: Mosby, 2001:641–93
3.
go back to reference Cheng EY, Springfield DS, Mankin HJ. Frequent incidence of extrapulmonary sites of initial metastasis in patients with liposarcoma. Cancer 1995; 75:1120–7PubMedCrossRef Cheng EY, Springfield DS, Mankin HJ. Frequent incidence of extrapulmonary sites of initial metastasis in patients with liposarcoma. Cancer 1995; 75:1120–7PubMedCrossRef
4.
go back to reference Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 1999; 85:85–92PubMedCrossRef Pearlstone DB, Pisters PW, Bold RJ, et al. Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer 1999; 85:85–92PubMedCrossRef
5.
go back to reference Spillane AJ, Fisher C, Thomas JM. Myxoid liposarcoma—the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol 1999; 6:389–94PubMedCrossRef Spillane AJ, Fisher C, Thomas JM. Myxoid liposarcoma—the frequency and the natural history of nonpulmonary soft tissue metastases. Ann Surg Oncol 1999; 6:389–94PubMedCrossRef
6.
go back to reference Estourgie SH, Nielsen GP, Ott MJ. Metastatic patterns of extremity myxoid liposarcoma and their outcome. J Surg Oncol 2002; 80:89–93PubMedCrossRef Estourgie SH, Nielsen GP, Ott MJ. Metastatic patterns of extremity myxoid liposarcoma and their outcome. J Surg Oncol 2002; 80:89–93PubMedCrossRef
7.
go back to reference Panagopoulos I, Mandahl N, Ron D, et al. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res 1994; 54:6500–3PubMed Panagopoulos I, Mandahl N, Ron D, et al. Characterization of the CHOP breakpoints and fusion transcripts in myxoid liposarcomas with the 12;16 translocation. Cancer Res 1994; 54:6500–3PubMed
8.
go back to reference Knight JC, Renwick PJ, Cin PD, Van den Berghe H, Fletcher CD. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 1995; 55:24–7PubMed Knight JC, Renwick PJ, Cin PD, Van den Berghe H, Fletcher CD. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res 1995; 55:24–7PubMed
9.
go back to reference Dal Cin P, Sciot R, Panagopoulos I, et al. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features. J Pathol 1997; 182:437–41PubMedCrossRef Dal Cin P, Sciot R, Panagopoulos I, et al. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: clinicopathological features. J Pathol 1997; 182:437–41PubMedCrossRef
10.
go back to reference Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Aman P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996; 12:489–94PubMed Panagopoulos I, Hoglund M, Mertens F, Mandahl N, Mitelman F, Aman P. Fusion of the EWS and CHOP genes in myxoid liposarcoma. Oncogene 1996; 12:489–94PubMed
11.
go back to reference Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of P53 status, LS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001; 7:3977–87PubMed Antonescu CR, Tschernyavsky SJ, Decuseara R, et al. Prognostic impact of P53 status, LS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res 2001; 7:3977–87PubMed
12.
go back to reference Smith TA, Easley KA, Goldblum JR. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 1996; 20:171–80PubMedCrossRef Smith TA, Easley KA, Goldblum JR. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol 1996; 20:171–80PubMedCrossRef
13.
go back to reference Kilpatrick SE, Doyon J, Choong PF, Sim FH, Nascimento AG. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996;77: 1450–8PubMedCrossRef Kilpatrick SE, Doyon J, Choong PF, Sim FH, Nascimento AG. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer 1996;77: 1450–8PubMedCrossRef
14.
go back to reference Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading system in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997;15: 350–62PubMed Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading system in a population of 410 adult patients with soft tissue sarcoma. J Clin Oncol 1997;15: 350–62PubMed
15.
go back to reference Nijhuis PH, Pras E, Sleijfer DT, Molenaar WM, Koops HS, Hoekstra HJ. Long-term results of preoperative intra-arterial doxorubicin combined with neoadjuvant radiotherapy, followed by extensive surgical resection for locally advanced soft tissue sarcomas of the extremities. Radiother Oncol 1999; 51:15–9PubMedCrossRef Nijhuis PH, Pras E, Sleijfer DT, Molenaar WM, Koops HS, Hoekstra HJ. Long-term results of preoperative intra-arterial doxorubicin combined with neoadjuvant radiotherapy, followed by extensive surgical resection for locally advanced soft tissue sarcomas of the extremities. Radiother Oncol 1999; 51:15–9PubMedCrossRef
16.
go back to reference Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002 Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6th ed. New York: Springer-Verlag, 2002
18.
go back to reference Kattan MW, Leung DHY, Brennan MF. A postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20:791–6PubMedCrossRef Kattan MW, Leung DHY, Brennan MF. A postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol 2002; 20:791–6PubMedCrossRef
Metadata
Title
Clinicopathologic Prognostic Factors in Myxoid Liposarcoma: A Retrospective Study of 49 Patients With Long-Term Follow-Up
Authors
Suzan E. ten Heuvel, MD
Harald J. Hoekstra, MD, PhD
Robert J. van Ginkel, MD, PhD
Esther Bastiaannet, MSc
Albert J. H. Suurmeijer, MD, PhD
Publication date
01-01-2007
Publisher
Springer-Verlag
Published in
Annals of Surgical Oncology / Issue 1/2007
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-006-9043-7

Other articles of this Issue 1/2007

Annals of Surgical Oncology 1/2007 Go to the issue

Letter to the Editor

Poor Prognosis for Biomarkers